Ion Beam Applications, S.A. Announces Revenue Results for the Year to Date Ended September 30, 2016; Provides Earnings Guidance for the Full Fiscal Year 2016
Revenues for the full-year expected to be around 20% higher than in 2015, reflecting strong PT growth and more than offsetting Dosimetry weakness; operating margin expected to be around 10%, slightly below previous expectations of 11% due to the weak Dosimetry market; the company expects operating margins to rise to 13-15% by 2018.